Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND2 pseudogene 6 (MTND2P6) is a nuclear pseudogene of the mitochondrial gene MT-ND2, which encodes an essential subunit of the mitochondrial NADH dehydrogenase (Complex I) involved in oxidative phosphorylation[2][7]. Unlike functional protein-coding genes, pseudogenes like MTND2P6 do not translate into proteins and generally lack direct biological function. Most research, functional, and disease associations center on MT-ND2, while studies of MTND2P6 itself are rare, and it is not considered a therapeutic target, receptor, enzyme, or transporter. Reports describing mitochondrial pseudogenes note that further research is needed to clarify their potential biological impact, but currently MTND2P6 is primarily noted for genomic annotation rather than clinical or experimental relevance[2][7]. This entry should not be used as a canonical therapeutic target due to its status as a pseudogene and lack of biological activity[2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND2 pseudogene 6 (MTND2P6).